Technical Analysis for DGX - Quest Diagnostics Incorporated

Grade Last Price % Change Price Change
A 161.32 0.10% 0.16
DGX closed up 0.1 percent on Wednesday, November 20, 2024, on approximately normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
Inside Day Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
Slingshot Bullish Bullish Swing Setup 0.10%
Spinning Top Other 0.10%
New 52 Week High Strength 0.10%
Stochastic Reached Overbought Strength 0.10%
Multiple of Ten Bullish Other 0.10%
Outside Day Range Expansion 0.10%
Overbought Stochastic Strength 0.10%
Upper Bollinger Band Touch Strength 0.10%

   Recent Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Quest Diagnostics Incorporated Description

Quest Diagnostics Incorporated provides diagnostic testing information services in the United States and internationally. The company operates in two businesses, Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business offers clinical testing services, including routine testing, gene-based and esoteric testing, anatomic pathology services, and drugs-of-abuse testing, as well as related services and insights. The Diagnostic Solutions business provides risk assessment services for the life insurance industry; clinical testing services for new drugs, vaccines, and medical devices; and clinical connectivity and data management solutions for healthcare organizations and clinicians to improve patient care and medical practice, as well as develops, manufactures, and markets diagnostics products. Its products include HemoCue, a point-of-care testing product for hemoglobin, glucose, microalbumin, and white blood cell testing; Care360 HER that allows doctors to electronically create, manage, and distribute patient encounter notes; and ChartMaxx, an electronic document management system for hospitals. The company offers its services to patients, physicians, hospitals, integrated delivery networks, health plans, employers, governmental institutions, and other commercial clinical laboratories through a network of laboratories and patient service centers. Quest Diagnostics Incorporated has a strategic alliance with Hologic, Inc. to offer testing based on Hologic's APTIMA family of products, as well as to co-develop and promote advanced diagnostic solutions to improve women's health. The company was founded in 1967 and is headquartered in Madison, New Jersey.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: S&P 500 Medicine Insurance Industry Glucose Lab Testing Diagnostic Products Document Management Healthcare Organizations Risk Assessment Hemoglobin Pathology Anatomical Pathology Medical Diagnosis Radiometer Data Management Solution Diagnostic Solutions Data Management Solutions Document Management System Pathology Services Point Of Care Testing Risk Assessment Services Sunquest Information Systems

Is DGX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 162.88
52 Week Low 121.0851
Average Volume 809,295
200-Day Moving Average 141.36
50-Day Moving Average 154.23
20-Day Moving Average 157.72
10-Day Moving Average 159.99
Average True Range 3.21
RSI (14) 61.39
ADX 15.4
+DI 21.81
-DI 20.74
Chandelier Exit (Long, 3 ATRs) 153.24
Chandelier Exit (Short, 3 ATRs) 160.97
Upper Bollinger Bands 163.18
Lower Bollinger Band 152.26
Percent B (%b) 0.83
BandWidth 6.93
MACD Line 2.23
MACD Signal Line 1.91
MACD Histogram 0.322
Fundamentals Value
Market Cap 17.98 Billion
Num Shares 111 Million
EPS 7.49
Price-to-Earnings (P/E) Ratio 21.54
Price-to-Sales 1.53
Price-to-Book 2.24
PEG Ratio 2.91
Dividend 2.84
Dividend Yield 1.76%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 164.34
Resistance 3 (R3) 164.23 163.13 163.83
Resistance 2 (R2) 163.13 162.36 163.18 163.66
Resistance 1 (R1) 162.22 161.88 161.67 162.33 163.50
Pivot Point 161.12 161.12 160.84 161.17 161.12
Support 1 (S1) 160.21 160.35 159.66 160.32 159.14
Support 2 (S2) 159.11 159.87 159.16 158.98
Support 3 (S3) 158.20 159.11 158.81
Support 4 (S4) 158.31